A Phase I, Randomized, Open-Label, Active Controlled, Multi-Center Pilot Study to Compare Reference to Reference Pharmacodynamics of BOTOX® (onabotulinumtoxinA) in Healthy Subjects. Protocol: MR 103A-0I-IPS-1001. lnformed Consent Form Version Dated 25 November 2022.,
Role: Investigator,
Mylan Pharmaceuticals,
(11/2023 - 03/2024)
Status: Completed
Internal
Tracking Quality of Life and Seizure Burden in Epilepsy Surgical Candidates in Inland Southern California,
Role: Investigator,
LLU Dept. of Neurology,
(03/2022)
Status: Approved
Randomized and placebo-controlled study to evaluate the effect of Magnesium sulfate on intraoperative neuromonitoring,
Role: Investigator,
LLU Dept. of Anesthesiology,
(04/2025 - 04/2026)
Status: Approved